pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
AWAKE-101
Pancreatic Ductal Adenocarcinoma
Loki Therapeutics Inc
0
catalysts
Phase 2
AXER-204
Chronic Spinal Cord Injury
ReNetX Bio
0
catalysts
AXUMIN
AXUMIN (FLUCICLOVINE F-18)
BLUE EARTH
0
catalysts
Preclinical
AXV-102
Axovia Therapeutics Ltd
0
catalysts
← prev
page 59 of 231
next →
131
Pain
89
Neurology
1
AZATHIOPRINE SODIUM
AZATHIOPRINE SODIUM (AZATHIOPRINE SODIUM)
HIKMA
0
catalysts
Phase 2
AZD-0120
Refractory Multiple Myeloma
Gracell Biotechnologies Inc
0
catalysts
Phase 2
AZD-0292
Bronchiectasis
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 3
AZD-1390
Recurrent Glioblastoma Multiforme (GBM)
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
AZD-5148
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
AZD-5863
Adenocarcinoma Of The Gastroesophageal Junction
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
AZD-7760
Staphylococcus aureus Infections
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 1
AZD-8965
Idiopathic Pulmonary Fibrosis
$AZN
ASTRAZENECA PLC
0
catalysts
AZELASTINE
AZELASTINE (AZELASTINE)
ALKEM LABS LTD
0
catalysts
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE)
TEVA PHARMS USA INC
0
catalysts
AZITHROMYCIN DIHYDRATE
AZITHROMYCIN DIHYDRATE (AZITHROMYCIN DIHYDRATE)
STRIDES PHARMA
0
catalysts
AZITHROMYCIN MONOHYDRATE
AZITHROMYCIN MONOHYDRATE (AZITHROMYCIN MONOHYDRATE)
Gland Pharma Ltd
0
catalysts
Phase 2
AbGn-268
Ulcerative Colitis
AltruBio Inc
0
catalysts
Marketed
Abrysvo
Respiratory Syncytial Virus (RSV) Infections
$PFE
PFIZER INC
0
catalysts
Preclinical
Ac-225 BisPSMA
Prostate Cancer
Clarity Pharmaceuticals Ltd
0
catalysts
Phase 2
Activated T Lymphocytes
Hepatocellular Carcinoma
Lukas Biomedical Inc
0
catalysts
Marketed
Acumin
Topotecan Hydrochloride (topotecan hydrochloride)
Small-Cell Lung Cancer
$PFE
PFIZER INC
0
catalysts
Preclinical
Acute Disseminated Encephalomyelitis
Encephalomyelitis
Trethera Corp
0
catalysts
Phase 2
AdAPT-001
Chondrosarcoma
EpicentRx Inc
0
catalysts
Phase 2
Adipose Tissue Derived Mesenchymal Stem Cells
Coronavirus Disease 2019 (COVID-19)
CellTex Therapeutics Corp
0
catalysts
Discontinued
Aduhelm
Aduhelm (aducanumab)
Alzheimer's disease (withdrawn from market 2024)
$BIIB
BIOGEN INC.
0
catalysts
Preclinical
Adze-1.17.C
Glioblastoma Multiforme (GBM)
Adze Biotechnology Inc
0
catalysts
Preclinical
AiSN Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Theranostec Inc
0
catalysts
Preclinical
Alcoholic Liver Disease
Alcohol Associated Liver Disease (ALD)
GeneToBe LLC
0
catalysts
Preclinical
AlgiaPak
Pain
Algia Pharma LLC
0
catalysts
Phase 2
AlloStemspine
olastrocel [INN]
Chronic Low Back Pain (CLBP)
$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
0
catalysts
